Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 8,169 $ 5,650 $ 22,575 $ 15,601
General and administrative 3,394 2,766 9,845 8,902
Total operating expenses 11,563 8,416 32,420 24,503
Loss from operations (11,563) (8,416) (32,420) (24,503)
Other income:        
Interest income 3 23 19 473
Net loss (11,560) (8,393) (32,401) (24,030)
Other comprehensive income:        
Net unrealized (loss) income on available-for-sale investments, net of tax (1) 1 (6) 12
Net comprehensive loss $ (11,561) $ (8,392) $ (32,407) $ (24,018)
Net loss per share of voting and non-voting common stock, basic and diluted $ (0.45) $ (0.36) $ (1.31) $ (1.09)